Search results

The management team regularly attends key industry conferences to meet investors and potential partners.

Oxford Biomedica is committed to its role as a responsible business and the Group has developed a policy and strategy to ensure it meets this objec

Oxford BioMedica - Website Privacy Notice

What personal information do we collect from you in the recruitment process?

Information on the Oxford BioMedica Directors and Senior Management can be found here.

Media enquiries

If you have a general media enquiry, please contact Oxford Biomedica at +44 1865 783 000

The LentiVector® platform is the only commercially approved lentiviral-based gene delivery system.

Pages